Clinical Pharmacology of Asparaginases in the United States: Asparaginase Population Pharmacokinetic and Pharmacodynamic (PK-PD) Models (NONMEM) in Adult and Pediatric ALL Patients-Reference-Cited by-同舟云学术

Clinical Pharmacology of Asparaginases in the United States: Asparaginase Population Pharmacokinetic and Pharmacodynamic (PK-PD) Models (NONMEM) in Adult and Pediatric ALL Patients

Published:2007-04 Issue:4 Volume:29 Page:239-247
ISSN:1077-4114
Container-title:Journal of Pediatric Hematology/Oncology
language:en
Short-container-title:

Author:

Avramis Vassilios I.,Spence Susan A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Reference36 articles.

1. Evidence that the L-asparaginase activity of guinea pig serum is responsible for its antilymphoma effects. I. Properties of the L-asparaginase of guinea pig serumin relation to those of the antilymphoma substance;Broome;J Exptl Med,1963

2. Two L-Asparaginases from E. coli and their action against tumors;Schwartz;Proc Natl Acad Sci,1966

3. A new L-asparaginase with anti-tumor activity;Wade;Lancet,1968

4. Inhibition of leukemias in man by L-asparaginase;Oettgen;Cancer Res,1967

5. Cancer Chemotherapy and Biotherapy, Principles and Practice. 2nd ed;Chabner,1996

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. L-asparaginase anti-tumor activity in pancreatic cancer is dependent on its glutaminase activity and resistance is mediated by glutamine synthetase;Experimental Cell Research;2023-05

2. Asparaginase: How to Better Manage Toxicities in Adults;Current Oncology Reports;2022-11-30

3. Pegylated Asparaginase‐Induced Liver Injury: A Case‐Based Review and Data From Pharmacovigilance;The Journal of Clinical Pharmacology;2022-04-14

4. Pharmacodynamics of cerebrospinal fluid asparagine after asparaginase;Cancer Chemotherapy and Pharmacology;2021-06-25

5. A systematic review of modeling and simulation approaches in designing targeted treatment technologies for Leukemia Cancer in low and middle income countries;Mathematical Biosciences and Engineering;2021